“PROSPECTS FOR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE FIRST LINE OF THERAPY FOR AGGRESSIVE NON-HODGKIN’S LYMPHOMAS”. Voprosy Onkologii, vol. 63, no. 2, Feb. 2017, pp. 326-8, https://doi.org/10.37469/0507-3758-2017-63-2-326-328.